| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 37.344 | 137.471 | 163.103 |
| Total Income - EUR | - | - | - | - | - | - | - | 37.626 | 137.471 | 163.110 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 100.445 | 213.563 | 248.389 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -62.819 | -76.092 | -85.279 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -62.819 | -76.092 | -85.279 |
| Employees | - | - | - | - | - | - | - | 3 | 4 | 4 |
Check the financial reports for the company - Tabi Farma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 63.784 | 50.849 | 39.376 |
| Current Assets | - | - | - | - | - | - | - | 52.842 | 62.259 | 63.210 |
| Inventories | - | - | - | - | - | - | - | 30.406 | 40.446 | 31.621 |
| Receivables | - | - | - | - | - | - | - | 19.236 | 20.784 | 20.896 |
| Cash | - | - | - | - | - | - | - | 3.200 | 1.028 | 10.693 |
| Shareholders Funds | - | - | - | - | - | - | - | -62.779 | -138.680 | -223.185 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 179.551 | 254.030 | 325.838 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Tabi Farma S.r.l.